Characterization of micro-invasive trabecular bypass stents by ex vivo perfusion and computational flow modeling

Kendall S Hunter,1 Todd Fjield,2 Hal Heitzmann,2 Robin Shandas,1 Malik Y Kahook3 1Department of Bioengineering, University of Colorado Denver, Aurora, CO, USA; 2Glaukos Corporation, Laguna Hills, CA, USA; 3University of Colorado Hospital Eye Center, Aurora, CO, USA Abstract: Micro-invasive glaucom...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hunter KS, Fjield T, Heitzmann H, Shandas R, Kahook MY
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/080b04e2e8ef4208abfec8a3bf68f1e9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:080b04e2e8ef4208abfec8a3bf68f1e9
record_format dspace
spelling oai:doaj.org-article:080b04e2e8ef4208abfec8a3bf68f1e92021-12-02T08:45:22ZCharacterization of micro-invasive trabecular bypass stents by ex vivo perfusion and computational flow modeling1177-5483https://doaj.org/article/080b04e2e8ef4208abfec8a3bf68f1e92014-03-01T00:00:00Zhttp://www.dovepress.com/characterization-of-micro-invasive-trabecular-bypass-stents-by-ex-vivo-a16051https://doaj.org/toc/1177-5483 Kendall S Hunter,1 Todd Fjield,2 Hal Heitzmann,2 Robin Shandas,1 Malik Y Kahook3 1Department of Bioengineering, University of Colorado Denver, Aurora, CO, USA; 2Glaukos Corporation, Laguna Hills, CA, USA; 3University of Colorado Hospital Eye Center, Aurora, CO, USA Abstract: Micro-invasive glaucoma surgery with the Glaukos iStent® or iStent inject® (Glaukos Corporation, Laguna Hills, CA, USA) is intended to create a bypass through the trabecular meshwork to Schlemm's canal to improve aqueous outflow through the natural physiologic pathway. While the iStent devices have been evaluated in ex vivo anterior segment models, they have not previously been evaluated in whole eye perfusion models nor characterized by computational fluid dynamics. Intraocular pressure (IOP) reduction with the iStent was evaluated in an ex vivo whole human eye perfusion model. Numerical modeling, including computational fluid dynamics, was used to evaluate the flow through the stents over physiologically relevant boundary conditions. In the ex vivo model, a single iStent reduced IOP by 6.0 mmHg from baseline, and addition of a second iStent further lowered IOP by 2.9 mmHg, for a total IOP reduction of 8.9 mmHg. Computational modeling showed that simulated flow through the iStent or iStent inject is smooth and laminar at physiological flow rates. Each stent was computed to have a negligible flow resistance consistent with an expected significant decrease in IOP. The present perfusion results agree with prior clinical and laboratory studies to show that both iStent and iStent inject therapies are potentially titratable, providing clinicians with the opportunity to achieve lower target IOPs by implanting additional stents. Keywords: glaucoma, iStent, trabecular bypass, intraocular pressure, ab-interno, CFDHunter KSFjield THeitzmann HShandas RKahook MYDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2014, Iss default, Pp 499-506 (2014)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Hunter KS
Fjield T
Heitzmann H
Shandas R
Kahook MY
Characterization of micro-invasive trabecular bypass stents by ex vivo perfusion and computational flow modeling
description Kendall S Hunter,1 Todd Fjield,2 Hal Heitzmann,2 Robin Shandas,1 Malik Y Kahook3 1Department of Bioengineering, University of Colorado Denver, Aurora, CO, USA; 2Glaukos Corporation, Laguna Hills, CA, USA; 3University of Colorado Hospital Eye Center, Aurora, CO, USA Abstract: Micro-invasive glaucoma surgery with the Glaukos iStent® or iStent inject® (Glaukos Corporation, Laguna Hills, CA, USA) is intended to create a bypass through the trabecular meshwork to Schlemm's canal to improve aqueous outflow through the natural physiologic pathway. While the iStent devices have been evaluated in ex vivo anterior segment models, they have not previously been evaluated in whole eye perfusion models nor characterized by computational fluid dynamics. Intraocular pressure (IOP) reduction with the iStent was evaluated in an ex vivo whole human eye perfusion model. Numerical modeling, including computational fluid dynamics, was used to evaluate the flow through the stents over physiologically relevant boundary conditions. In the ex vivo model, a single iStent reduced IOP by 6.0 mmHg from baseline, and addition of a second iStent further lowered IOP by 2.9 mmHg, for a total IOP reduction of 8.9 mmHg. Computational modeling showed that simulated flow through the iStent or iStent inject is smooth and laminar at physiological flow rates. Each stent was computed to have a negligible flow resistance consistent with an expected significant decrease in IOP. The present perfusion results agree with prior clinical and laboratory studies to show that both iStent and iStent inject therapies are potentially titratable, providing clinicians with the opportunity to achieve lower target IOPs by implanting additional stents. Keywords: glaucoma, iStent, trabecular bypass, intraocular pressure, ab-interno, CFD
format article
author Hunter KS
Fjield T
Heitzmann H
Shandas R
Kahook MY
author_facet Hunter KS
Fjield T
Heitzmann H
Shandas R
Kahook MY
author_sort Hunter KS
title Characterization of micro-invasive trabecular bypass stents by ex vivo perfusion and computational flow modeling
title_short Characterization of micro-invasive trabecular bypass stents by ex vivo perfusion and computational flow modeling
title_full Characterization of micro-invasive trabecular bypass stents by ex vivo perfusion and computational flow modeling
title_fullStr Characterization of micro-invasive trabecular bypass stents by ex vivo perfusion and computational flow modeling
title_full_unstemmed Characterization of micro-invasive trabecular bypass stents by ex vivo perfusion and computational flow modeling
title_sort characterization of micro-invasive trabecular bypass stents by ex vivo perfusion and computational flow modeling
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/080b04e2e8ef4208abfec8a3bf68f1e9
work_keys_str_mv AT hunterks characterizationofmicroinvasivetrabecularbypassstentsbyexvivoperfusionandcomputationalflowmodeling
AT fjieldt characterizationofmicroinvasivetrabecularbypassstentsbyexvivoperfusionandcomputationalflowmodeling
AT heitzmannh characterizationofmicroinvasivetrabecularbypassstentsbyexvivoperfusionandcomputationalflowmodeling
AT shandasr characterizationofmicroinvasivetrabecularbypassstentsbyexvivoperfusionandcomputationalflowmodeling
AT kahookmy characterizationofmicroinvasivetrabecularbypassstentsbyexvivoperfusionandcomputationalflowmodeling
_version_ 1718398344888320000